System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy
The radiofrequency/microwave hyperthermia system for benign prostatic hyperplasia (BPH) thermotherapy is a urology device that delivers controlled heat to the prostate gland to reduce its size and relieve lower urinary tract symptoms in patients with BPH. It is classified as FDA Class III, requiring Premarket Approval (PMA) with clinical evidence of safety and effectiveness. The product code is MEQ and no regulation number or formal medical specialty has been assigned. The device is not an implant and does not sustain life.
Research product code MEQ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- MEQ
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- GU
- Submission Type
- 2
Device Characteristics
FEI Numbers
This FDA classification entry is associated with 9 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 9 registration numbers. Click on an entry to view related FDA registrations.